EUVIMEDEUVIMED entdecken
Open Access

Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution

Nora Pisanic iD, Annukka A R Antar iD, Marissa K Hetrich iD, Zoe O Demko iD, Xueyan Zhang, Kristoffer Spicer, Kate L Kruczynski, Barbara Detrick iD, William Clarke, Maria Deloria Knoll iD, David L Thomas, Fatimah S Dawood und 4 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Nora Pisanic und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Immunoglobulin A, Secretory, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIEHS NIH HHS, Henry M. Jackson Foundation for the Advancement of Military Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Efforts are underway to support the development of novel mucosal coronavirus disease 2019 (COVID-19) vaccines. However, there is limited consensus about the complementary role of mucosal immunity in disease progression and how to evaluate immunogenicity of mucosal vaccines. This study investigated the role of oral mucosal antibody responses in viral clearance and COVID-19 symptom duration.

Methods

Participants with polymerase chain reaction (PCR)–confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provided oral fluid for testing with SARS-CoV-2 antibody multiplex assays, nasal swabs for reverse-transcription PCR, and symptom information at up to 8 follow-ups from April 2020 to February 2022.

Results

High and moderate oral fluid anti-spike (S) secretory IgA (SIgA) postinfection was associated with significantly faster viral clearance and symptom resolution across age groups with effect sizes equivalent to prior COVID-19 vaccine immunity at the time of infection. Those with high and moderate anti-S SIgA cleared the virus 14 (95% confidence interval [CI], 10–18) days and recovered 9–10 (95% CI, 6–14) days earlier. Delayed and higher anti-S IgG was associated with significantly longer time to clearance and recovery. Experiencing symptoms >4 weeks was associated with lower anti–receptor-binding domain SIgA 15–30 days after infection onset (P < .001).

Conclusions

Robust mucosal SIgA early postinfection appears to support faster clearance of SARS-CoV-2 and recovery from COVID-19 symptoms. This research underscores the importance of harmonizing mucosal immune response assays to evaluate new mucosal vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Immunoglobulin A, SecretorySpike Glycoprotein, CoronavirusImmunoglobulin GAntibodies, ViralSalivaHumansMaleFemaleAdultMiddle AgedImmunity, MucosalAgedYoung AdultAdolescentMouth Mucosa

Stichwörter der Autor:innen

COVID-19intranasal vaccineslong COVIDmucosal immunityoral fluid

Substanzen

Immunoglobulin A, SecretorySpike Glycoprotein, CoronavirusImmunoglobulin GAntibodies, Viralspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
  • Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
  • Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

ORCID-Profile: Nora Pisanic, Annukka A R Antar, Marissa K Hetrich, Zoe O Demko, Barbara Detrick, Maria Deloria Knoll, Vic Veguilla, Ruth A Karron, Yukari C Manabe, Christopher D Heaney

Förderung

  • NIAID NIH HHS
  • NIEHS NIH HHS
  • Henry M. Jackson Foundation for the Advancement of Military Medicine
  • Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program
  • Johns Hopkins COVID-19 Research Response Program
  • FIA Foundation
  • NIH HHS
  • CDC HHS

Zitieren

APA

Pisanic, N., Antar, A. A. R., Hetrich, M. K., Demko, Z. O., Zhang, X., Spicer, K., Kruczynski, K. L., Detrick, B., Clarke, W., Knoll, M. D., Thomas, D. L., Dawood, F. S., Veguilla, V., Karron, R. A., Manabe, Y. C., & Heaney, C. D. (2025). Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae447

Vancouver

Pisanic N, Antar AAR, Hetrich MK, Demko ZO, Zhang X, Spicer K, et al. Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae447

BibTeX
@article{Pisanic2025,
  author = {Pisanic, Nora and Antar, Annukka A R and Hetrich, Marissa K and Demko, Zoe O and Zhang, Xueyan and Spicer, Kristoffer and Kruczynski, Kate L and Detrick, Barbara and Clarke, William and Knoll, Maria Deloria and Thomas, David L and Dawood, Fatimah S and Veguilla, Vic and Karron, Ruth A and Manabe, Yukari C and Heaney, Christopher D},
  title = {Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae447}
}
Kostenlos starten →